GL1X · GenesisL1 explorer

MolNFT v1 · #85792 · protein

Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (gdc-0973), or related analogs.

4AN3 · Dual specificity mitogen-activated protein kinase kinase 1: “Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (gdc-0973), or related…”. X-ray diffraction, 3 ligands (ATP, 5Y0, MG), 2 pockets (best…

PDB
4AN3
Type
protein
Length
280 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity mitogen-activated protein kinase kinase 1
EC
2.7.12.2
UniProt
Q02750
Ligands
ATP, 5Y0, MG
Pockets
2 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual specificity mitogen-activated protein kinase kinase 1 (EC 2.7.12.2)protein28045% helix, 18% strandQ02750

Ligands and binding sites

  • ATP · Adenosine-5'-triphosphate · ligand · chains A
  • 5Y0 · N-[(2S)-2,3-bis(oxidanyl)propoxy]-3,4-bis(fluoranyl)-2-[(2-fluoranyl-4-iodanyl-phenyl)amino]benzamide · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16910.790.8464MG, ATP, 5Y0
2530.290.7513empty

Compared structures

  • 4AN3 · Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q02750 · AlphaFold monomer V2.0 prediction for dual specificity mitogen- activated protein kinase… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.